Pharmedic Pharmaceutical Medicinal JSC
HHNX:PMC119,300.00
VND
-3,900.00
(-3.17%)
ISIN
VN000000PMC3
Return %
Stock
S&P 500
1Y
0.59
14.20
3Y
47.28
81.12
5Y
84.96
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Trung Viet Tran
- Full Time Employees
- 516
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Ho Chi Minh City Vietnam
- IPO Date
- Oct 9, 2009
- Website
- pharmedic.com.vn
- Similar Companies
- Business
- Pharmedic Pharmaceutical Medicinal Joint Stock Company is a Vietnam-based pharmaceutical enterprise engaged in the manufacturing, processing, marketing, import, and export of finished pharmaceuticals, medicinal products, antiseptic solutions, cosmetics, medical supplies, and dietary supplements. Founded in 1981 and headquartered in Ho Chi Minh City, Vietnam, the company distributes its healthcare portfolio across national hospital (ETC) networks, prescription and over-the-counter (OTC) retail pharmacies, and regional export markets. The company offers a diverse product portfolio structured across multiple therapeutic and consumer health categories: topical antiseptics and disinfectants, prominently anchored by the Povidine brand line, including povidone-iodine skin antiseptic solutions, surgical scrubs, gargles, vaginal solutions, and topical ointments; ophthalmic, otic, and nasal preparations, comprising sodium chloride physiological eye/nasal washes, multivitamin drops, and antimicrobial solutions; dermatological treatments, encompassing antifungal creams, hydrocortisone ointments, anti-inflammatory gels, and topical lotions; oral medicines, including antipyretics, analgesics, cough and cold preparations, mucolytics, and gastrointestinal agents; feminine hygiene solutions and specialized medical skin cleansers, such as the Gyno-Pharm line; and medical-grade ethanol solutions, diagnostic support consumables, and nutritional vitamin supplements. In addition to proprietary pharmaceutical manufacturing, the company provides toll manufacturing, pharmaceutical formulation processing, contract packaging, and wholesale logistics services. In recent developments, Pharmedic has focused on modernizing and expanding its production infrastructure at the Cat Lai Industrial Zone facility in Ho Chi Minh City, upgrading cleanrooms and automated lines for sterile ophthalmic preparations and topical liquids in alignment with WHO-GMP, GLP, and GSP standards. The company has deepened its commercial reach by expanding nationwide retail distribution agreements with leading modern pharmacy chains, including FPT Long Chau, Pharmacity, and An Khang, while executing strategic product line extensions in over-the-counter eye care, daily health hygiene, and preventative wellness supplements. Operationally, Pharmedic has strengthened its raw material procurement partnerships to mitigate global active pharmaceutical ingredient supply chain disruptions, optimized manufacturing yields, and maintained consistent capital returns through established cash dividend distribution policies.